IP Library › Granted Patent US 10,881,341
Granted Patent B1
US 10,881,341 · App. 17/030,053 · Granted Jan 5, 2021

Medical device inserters and processes of inserting and using medical devices

Inventors: Samuel M. Curry (Oakland, CA); Manuel L. Donnay (San Francisco, CA); Tuan Nguyen (Dublin, CA); Louis G. Pace (San Carlos, CA); Peter G. Robinson (Alamo, CA); Phillip Yee (San Francisco, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61B5/150022A61B5/1411A61B5/14503A61B5/14532A61B5/14542A61B5/14546A61B5/157A61B5/1513A61B5/1519A61B5/15087A61B5/15107A61B5/15113A61B5/15117A61B5/15186A61B5/15194A61B5/150259A61B5/150282A61B5/150396A61B5/150419A61B5/150427A61B5/150511A61B5/6865A61B17/34A61M5/158A61B5/0002A61B5/01A61B5/15016A61B5/150732A61M2005/1585
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,341
App. No.
17/030,053
Granted
Jan 5, 2021
Kind
B1
Abstract

An apparatus for insertion of a medical device in the skin of a subject is provided, as well as methods of inserting medical devices.

Claims (55)

1. A glucose monitoring system comprising:

an insertion assembly for inserting a glucose sensor into a subject, the insertion assembly comprising:

the glucose sensor, wherein a distal end of the glucose sensor is configured to be inserted under skin of the subject;

a distal surface including an adhesive layer, wherein the distal surface is configured to be positioned on the skin of the subject such that the adhesive layer adheres to the skin of the subject;

an interior of the insertion assembly including a first spring in a loaded position, a second spring, a sliding member, and a straight track having a length, wherein the sliding member is configured to move only within the straight track; and

a button configured to be pressed along a first axis toward the interior of the insertion assembly,

wherein the button is further configured to release the first spring from the loaded position upon being pressed, such that the first spring causes the sliding member to move within the straight track along a second axis different from the first axis, wherein the second axis is defined by the length of the straight track,

wherein movement of the sliding member within the straight track causes an actuator to advance in a distal direction along an insertion axis different from the first axis and the second axis, wherein advancement of the actuator causes advancement of a sharp and the glucose sensor in the distal direction along the insertion axis such that the distal end of the glucose sensor is inserted under the skin of the subject,

wherein the sliding member is further configured to continue moving within the straight track after the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis,

wherein the sliding member is operatively engaged with the actuator throughout the movement of the sliding member within the straight track during and after the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis,

wherein, the second spring is configured to expand and retract the sharp in a proximal direction along the insertion axis while the distal end of the glucose sensor remains under the skin of the subject,

wherein the second spring is a compression spring, and

wherein the glucose sensor is configured to operate for a period of about seven days or more.

2. The glucose monitoring system of claim 1 , wherein, after the release of the first spring from the loaded position, the first spring is configured to cause a rotatable member to rotate less than a full rotation.

3. The glucose monitoring system of claim 2 , wherein the insertion assembly further comprises a stopping surface, wherein the stopping surface is configured to stop the rotation of the rotatable member.

4. The glucose monitoring system of claim 1 , wherein the first spring is a torsion spring.

5. The glucose monitoring system of claim 1 , wherein the second axis is perpendicular to the insertion axis.

6. The glucose monitoring system of claim 1 , wherein the second axis is perpendicular to the first axis.

7. The glucose monitoring system of claim 1 , wherein the second axis is perpendicular to the first axis and the insertion axis.

8. The glucose monitoring system of claim 1 , wherein an end section of the glucose sensor is configured to be in contact with interstitial fluid of the subject after the distal end of the glucose sensor is inserted under the skin of the subject.

9. The glucose monitoring system of claim 1 , wherein at least a part of the glucose sensor is housed within the sharp.

10. The glucose monitoring system of claim 1 , wherein the glucose sensor is configured to operate for a period of about ten days.

11. The glucose monitoring system of claim 1 , wherein the insertion assembly further comprises a mount, wherein the mount is configured to be secured to the skin of the subject before advancement of the sharp and the glucose sensor in the distal direction along the insertion axis.

12. The glucose monitoring system of claim 1 , further comprising on body electronics, wherein the on body electronics are configured to be installed, without use of the insertion assembly, after the advancement of the glucose sensor in the distal direction along the insertion axis.

13. The glucose monitoring system of claim 12 , wherein the on body electronics are configured to be coupled with the glucose sensor.

14. The glucose monitoring system of claim 13 , wherein the on body electronics are configured to provide a voltage to the glucose sensor.

15. The glucose monitoring system of claim 13 , wherein the on body electronics are configured to provide a current to the glucose sensor.

16. The glucose monitoring system of claim 13 , wherein the glucose sensor is a first glucose sensor, and wherein the on body electronics are configured to be used with a second glucose sensor after being used with the first glucose sensor.

17. The glucose monitoring system of claim 13 , wherein the glucose sensor comprises a proximal retention portion, a distal insertion portion, and a bendable portion located therebetween.

18. The glucose monitoring system of claim 17 , wherein the bendable portion of the glucose sensor is configured to bend prior to coupling of the on body electronics with the glucose sensor.

19. The glucose monitoring system of claim 17 , wherein the bendable portion of the glucose sensor is configured to bend during coupling of the on body electronics with the glucose sensor.

20. The glucose monitoring system of claim 17 , wherein the proximal retention portion of the glucose sensor is configured to be substantially perpendicular to the distal insertion portion of the glucose sensor after coupling of the on body electronics with the glucose sensor.

21. The glucose monitoring system of claim 12 , wherein the on body electronics comprise a power supply, a processor, memory, and communications circuitry configured to wirelessly communicate data indicative of a glucose level.

22. The glucose monitoring system of claim 12 , wherein at least a portion of the on body electronics is configured to be in a low power state, a no power state, or an inactive mode before the advancement of the glucose sensor in the distal direction along the insertion axis.

23. The glucose monitoring system of claim 12 , wherein the glucose sensor has a predetermined glucose monitoring time period and wherein, after the expiration of the predetermined glucose monitoring time period, at least a portion of the on body electronics is configured to be deactivated or disabled.

24. The glucose monitoring system of claim 1 , further comprising a display device, wherein the glucose sensor has a predetermined glucose monitoring time period, and wherein, after the expiration of the predetermined glucose monitoring time period, at least a portion of the display device is configured to be deactivated or disabled.

25. The glucose monitoring system of claim 1 , wherein the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis and the retraction of the sharp in the proximal direction along the insertion axis occur automatically after the button is pressed.

26. A glucose monitoring system comprising:

an insertion assembly for inserting a glucose sensor into a subject, the insertion assembly comprising:

the glucose sensor, wherein a distal end of the glucose sensor is configured to be inserted under skin of the subject;

a sharp, wherein at least a part of the glucose sensor is housed within the sharp;

a distal surface including an adhesive layer, wherein the distal surface is configured to be positioned on the skin of the subject such that the adhesive layer adheres to the skin;

an interior of the insertion assembly including a first spring in a loaded position, a second spring, a sliding member, and a straight track having a length, wherein the sliding member is configured to move only within the straight track; and

a button configured to be pressed along a first axis toward the interior of the insertion assembly,

wherein the button is further configured to release the first spring from the loaded position upon being pressed, such that the first spring causes the sliding member to move within the straight track along a second axis different from the first axis, wherein the second axis is defined by the length of the straight track,

wherein movement of the sliding member within the straight track causes an actuator to advance in a distal direction along an insertion axis different from the first axis and the second axis, wherein advancement of the actuator causes advancement of the sharp and the glucose sensor in the distal direction along the insertion axis such that the distal end of the glucose sensor is inserted under the skin of the subject,

wherein the sliding member is further configured to continue moving within the straight track after the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis,

wherein the sliding member is operatively engaged with the actuator throughout the movement of the sliding member within the straight track during and after the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis,

wherein the second spring is configured to expand and retract the sharp in a proximal direction along the insertion axis while the distal end of the glucose sensor remains under the skin of the subject,

wherein the second spring is a compression spring, and

wherein the glucose sensor is configured to operate for a period of about seven days or more.

27. The glucose monitoring system of claim 26 , wherein the first spring is a torsion spring, and wherein the insertion assembly further comprises a mount, wherein the mount is configured to be secured to the skin of the subject before the advancement of the sharp and the glucose sensor in the distal direction along the insertion axis.

28. The glucose monitoring system of claim 27 , further comprising on body electronics, wherein the on body electronics are configured to be installed, without use of the insertion assembly, after the advancement of the glucose sensor in the distal direction along the insertion axis, wherein the on body electronics are configured to be coupled with the glucose sensor, and wherein the on body electronics comprise a power supply, a processor, memory, and communications circuitry configured to wirelessly communicate data indicative of a glucose level.

29. The glucose monitoring system of claim 28 , wherein the second axis is perpendicular to the insertion axis, and wherein, after the release of the first spring from the loaded position, the first spring is configured to cause a rotatable member to rotate less than a full rotation.

30. The glucose monitoring system of claim 29 , wherein the insertion assembly further comprises a stopping surface, wherein the stopping surface is configured to stop the rotation of the rotatable member.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2020
From: CURRY, SAMUEL M.; DONNAY, MANUEL L.; NGUYEN, TUAN; PACE, LOUIS G.; ROBINSON, PETER G.; YEE, PHILLIP
To: ABBOTT DIABETES CARE INC.
Reel/Frame 053871/0473 →
Continuity (6)
Continuation 14996751 · Jan 15, 2016
Continuation 13071487 · Mar 24, 2011
Provisional Application 61411262 · Nov 8, 2010
Provisional Application 61361374 · Jul 2, 2010
Provisional Application 61345562 · May 17, 2010
Provisional Application 61317243 · Mar 24, 2010
Cited By (56)
US 1,130,751 US 12,239,442 US 12,239,463 US 12,268,496 US 12,274,548 US 12,274,549 US 12,279,866 US 12,279,867 US 12,279,868 US 12,285,251 US 12,285,252 US 12,310,722 US 12,313,622 US 12,315,630 US 12,326,441 US 12,329,522 US 12,343,140 US 12,350,042 US 12,369,821 US 12,390,132 US 12,408,847 US 12,414,713 US 12,436,127 US 12,440,173 US 12,465,251 US 12,478,296 US 12,482,558 US 12,495,993 US 12,502,101 US 12,502,132 US 12,521,041 US 12,558,007 US 12,558,122 US 12,562,273 US 12,569,166 US 12,569,168 US 12,569,173 US 12,575,763 US 12,575,856 US 12,576,599 US 12,582,334 US 12,588,928 US 12,589,204 US 12,599,317 US 12,605,185 US 12,605,186 US 12,611,121 US 12,611,125 US 12,616,395 US 12,616,396 US 12,616,397 US 12,629,173 US 12,666,543 US 12,667,286 US 12,690,789 US 12,702,332